This study aims to evaluate the prognostic utility of admission levels of PT-INR, IL-6, and HDL cholesterol in severe sepsis patients, correlating these biomarkers with clinical severity and outcomes to improve early prognostication and treatment strategies in resource-limited ICU settings. Here, IL6 is linked to Sepsis.